Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Surgery vs Medical Therapy for Diabetic Kidney Disease
NCT04626323Phase 2Unknown
- Sponsor
- Hospital Alemão Oswaldo Cruz
- Start
- May 2021
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Hospital Alemão Oswaldo Cruz. Primary endpoint: Glomerular filtration rate at 36 months. Status: unknown.
Beyond the preview
Go deeper on NCT04626323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04626323.